LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration
NCT ID: NCT05570929
Last Updated: 2024-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
20 participants
OBSERVATIONAL
2023-02-07
2026-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring Kidney Function in Kidney Transplantation
NCT00212979
Immunosuppression's Long Term Impact on Anti-tumoral Oversight in Kidney Transplantation
NCT03227965
Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China
NCT01796639
Multimorbidity and Cardiovascular Risk Factors After Renal Transplant
NCT07205692
Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine
NCT03024229
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Kidney Donor
Defined as a human individual donating a kidney
No interventions assigned to this group
Kidney Recipient
Defined as a patient suffering from chronic kidney disease being the recipient of a kidney transplant
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned living kidney donation / transplantation
Exclusion Criteria
* Postoperative phase
* Acute infections
* Vegan diet
* Change of body weight of more than 10% in the month prior to study entry
* Known drug or alcohol abuse
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Till Schütte
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicola Wilck, MD
Role: PRINCIPAL_INVESTIGATOR
Charite University, Berlin, Germany
Hendrik Bartolomaeus, MD
Role: PRINCIPAL_INVESTIGATOR
Charite University, Berlin, Germany
Anja Mähler, PhD
Role: PRINCIPAL_INVESTIGATOR
Charite University, Berlin, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Experimental and Clinical Research Center
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LONGKID
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.